EQUILLIUM BIO

Equillium is a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need... Equillium is actively recruiting individuals to participate in clinical trials for alopecia areata, celiac disease, acute graft-versus-host disease (aGVHD) and lupus nephritis... At Equillium, we leverage a deep understanding of immunology and its role in disease to pioneer new products for severe autoimmune and inflammatory disorders.

Also known as: Equillium, Equillium, Inc.

Primary location: La Jolla United States